Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.1.17 (
ornithine decarboxylase
)
6,351
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
LH plays a relevant role in folliculogenesis, ovulation, and luteinization. Although
ornithine decarboxylase
(
ODC
), a key enzyme in polyamine biosynthesis, is a target of LH in the ovary, the functional significance of
ODC
induction has remained elusive. Our study reveals that the blockade of the induction of ovarian
ODC
by means of the specific inhibitor alpha-difluoromethylornithine (DFMO) affects folliculogenesis and luteinization. In immature female mice, DFMO was found to inhibit ovarian growth, the formation of Graafian follicles, and the secretion of progesterone and estradiol. In adult cycling females, the administration of DFMO on the evening/night of proestrus markedly decreased plasma progesterone levels at diestrus, which was associated to the decrease in the expression of
steroidogenic factor 1
, cytochrome cholesterol side chain cleavage enzyme, and steroidogenic acute regulatory protein in the ovary and to a reduced vascularization of the corpora lutea. These effects were not reverted by the administration of gonadotropins or prolactin.
ODC
immunoreactivity was also stimulated by LH in theca and granulosa cells of antral follicles but not in preantral follicles. Overall, these experiments demonstrate that elevated
ODC
values found in the ovary of immature and adult mice play a relevant function in ovarian physiology and that
ODC
/polyamines must be considered as important mediators of some of the effects of LH on follicular development and luteinization.
...
PMID:Influence of ovarian ornithine decarboxylase in folliculogenesis and luteinization. 1551 84